Literature DB >> 10602341

Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation.

Y C Shen1, C F Chen, Y J Sung.   

Abstract

1. We have previously shown that tetrandrine (TTD), a bisbenzyltetrahydroiosquinoline isolated from the Chinese herb Stephania tetrandra, inhibits neutrophil adhesion, Mac-1 expression, and reactive oxygen species (ROS) production. To examine whether inhibition of neutrophil function may confer upon TTD the ability to prevent myocardial ischaemia-reperfusion (MI/R) injury, experiments were performed on rats subjected to coronary ligation followed by reperfusion for induction of MI/R injury. 2. Intravenous administration of TTD (0.1 and 1.0 mg kg-1) 15 min prior to coronary ligation completely prevented MI/R-associated mortality. TTD pretreatment also significantly reduced MI/R-induced ventricular tachyarrhythmia, myocardial infarct size, and neutrophil infiltration. 3. However, TTD pretreatment did not influence mean arterial blood pressure, heart rate, or product of pressure-rate, indicating that TTD extenuated MI/R through mechanisms independent of modulating haemodynamics or myocardial oxygen demand. 4. Peripheral blood neutrophils were isolated for ex vivo examination of shape change and Mac-1 upregulation of neutrophils, two sensitive indicators of proinflammatory priming, as well as N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced adhesion and ROS production, parameters commonly used for the assessment of neutrophil activation. 5. Neutrophils from MI/R animals showed significant shape change and Mac-1 upregulation, both of which were prevented by TTD-pretreatments. On the other hand, fMLP-induced adhesion and ROS production of neutrophils were markedly enhanced by MI/R but diminished in TTD-pretreated animals. 6. These data suggest that the protective effect of TTD against MI/R injury can be accounted for by inhibition of neutrophil priming and activation, thereby abolishing subsequent infiltration and ROS production that cause MI/R injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602341      PMCID: PMC1571794          DOI: 10.1038/sj.bjp.0702958

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  The effect of neutrophil depletion on reperfusion arrhythmias during intracoronary thrombolysis using the leukocyte removal filter.

Authors:  Y Kutsumi; T Misawa; H Tada; S S Kim; T Nakai; S Miyabo; T Nishimura; H Kamata; S Nakanishi
Journal:  ASAIO Trans       Date:  1989 Jul-Sep

2.  Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium.

Authors:  W J Dreyer; C W Smith; L H Michael; R D Rossen; B J Hughes; M L Entman; D C Anderson
Journal:  Circ Res       Date:  1989-12       Impact factor: 17.367

3.  Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury.

Authors:  L O Go; C E Murry; V J Richard; G R Weischedel; R B Jennings; K A Reimer
Journal:  Am J Physiol       Date:  1988-11

4.  Flow cytometric assessment of NADPH oxidase inhibitors in whole blood.

Authors:  W Haston; J H van Duzer; J C Quintavalla
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

5.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.

Authors:  M R Litt; R W Jeremy; H F Weisman; J A Winkelstein; L C Becker
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

6.  Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 Up-regulation and adhesion by tetrandrine.

Authors:  Y C Shen; C F Chen; S Y Wang; Y J Sung
Journal:  Mol Pharmacol       Date:  1999-01       Impact factor: 4.436

7.  The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

Authors:  M J Walker; M J Curtis; D J Hearse; R W Campbell; M J Janse; D M Yellon; S M Cobbe; S J Coker; J B Harness; D W Harron
Journal:  Cardiovasc Res       Date:  1988-07       Impact factor: 10.787

8.  Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.

Authors:  G L Stahl; Z Terashita; A M Lefer
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

9.  Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism.

Authors:  M L Entman; K Youker; S B Shappell; C Siegel; R Rothlein; W J Dreyer; F C Schmalstieg; C W Smith
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 10.  Free radicals in ischemic and reperfusion myocardial injury: is this the time for clinical trials?

Authors:  M V Cohen
Journal:  Ann Intern Med       Date:  1989-12-01       Impact factor: 25.391

View more
  14 in total

1.  The effects of exogenous l-carnitine on lipid peroxidation and tissue damage in an experimental warm hepatic ischemia-reperfusion injury model.

Authors:  Hakan Canbaz; Tamer Akca; Canten Tataroglu; Mehmet Caglikulekci; Musa Dirlik; Lokman Ayaz; Ali Bora Ustunsoy; Bahar Tasdelen; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2007-01

Review 2.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

3.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

4.  Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver.

Authors:  Abdurrahman Karaman; Ersin Fadillioglu; Emine Turkmen; Erkan Tas; Zumrut Yilmaz
Journal:  Pediatr Surg Int       Date:  2006-03-24       Impact factor: 1.827

5.  Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver.

Authors:  Zhongmin Liu; Zhenping Xu; Wenlu Shen; Yi Li; Jun Zhang; Xin Ye
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

6.  Inhibitory effects of tetrandrine on the Na(+) channel of human atrial fibrillation myocardium.

Authors:  Li Chen; Qi-Yong Li; Yan Yang; Zhong-Wen Li; Xiao-Rong Zeng
Journal:  Acta Pharmacol Sin       Date:  2009-01-19       Impact factor: 6.150

7.  Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase.

Authors:  Yu Wang; Xinjun Cai; Zhiheng Wu; Leilei Tang; Lingqun Lu; Yinyin Xu; Xiaogang Bao
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

8.  Tetrandrine protects mouse retinal ganglion cells from ischemic injury.

Authors:  Weiyi Li; Chen Yang; Jing Lu; Ping Huang; Colin J Barnstable; Chun Zhang; Samuel S Zhang
Journal:  Drug Des Devel Ther       Date:  2014-03-21       Impact factor: 4.162

Review 9.  Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.

Authors:  Qing Liu; Jiqiang Li; Jing Wang; Jianping Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-31       Impact factor: 2.629

Review 10.  Anti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after Stroke.

Authors:  Jiannan Chen; Xiangjian Zhang; Cong Zhang; Wenhui Wang; Rong Chen; Honglei Jiao; Linlin Li; Lan Zhang; Lili Cui
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.